UBS Group AG - BONE BIOLOGICS CORP ownership

BONE BIOLOGICS CORP's ticker is and the CUSIP is 098070303. A total of 4 filers reported holding BONE BIOLOGICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BONE BIOLOGICS CORP
ValueSharesWeighting
Q1 2023$11,306
+252.8%
43,653
+186.0%
0.00%
Q4 2022$3,205
-70.9%
15,263
+98.9%
0.00%
Q2 2022$11,0007,673
+8927.1%
0.00%
Q1 2022$0850.00%
Other shareholders
BONE BIOLOGICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
JANE STREET GROUP, LLC 13,464$37,0000.00%
UBS Group AG 85$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Citadel Advisors 10,741$30,0000.00%
VANGUARD GROUP INC 33,461$93,0000.00%
View complete list of BONE BIOLOGICS CORP shareholders